[1]
Metelkin, I. 2026. Multicriteria Decision Modeling for the Inclusion of Generic Medicines and Biosimilars in Reimbursement Systems. The American Journal of Medical Sciences and Pharmaceutical Research. 8, 09 (Sep. 2026), 16–27. DOI:https://doi.org/10.37547/tajmspr/Volume08Issue09-01.